Novartis AG is 21.9x more valuable than Axsome Therapeutics, Inc. by market capitalization ($282.64 B vs $12.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AXSM | NVS |
|---|---|---|
| Market cap | $12.91 B | $282.64 B |
| US-listed rank | #801 | #47 |
| Revenue (latest FY) | $638.50M | - |
| Net income (latest FY) | -$183.17M | - |
| Net margin | -28.7% | - |
| SEC filings | 634 | 947 |
Novartis AG is 21.9x more valuable than Axsome Therapeutics, Inc. by market capitalization ($282.64 B vs $12.91 B).
Full pages: Axsome Therapeutics, Inc. and Novartis AG, or browse the full rankings.